Influenza News and Research

Latest Influenza News and Research

New SARS-CoV-2 genome variants identified in US mink

Researchers in Canada have discovered two novel variants in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gene sequences collected from mink in the United States.

28 Mar 2021

Covid-19 lockdown restrictions may have led to reduction in asthma exacerbations

Fewer patients with severe attacks were seen by their GP or admitted to hospital during the covid-19 pandemic, and fewer were admitted to hospital for pneumonia, influenza and chronic lung diseases, show findings from three papers published online in the journal Thorax.

27 Mar 2021

POSTECH researchers produce artificial lung model using 3D printing

The warmer temperature and blooming flowers signal the arrival of spring. However, worries about respiratory diseases are also on the rise due to fine dust and viruses.

26 Mar 2021

Study: COVID-19 vaccines may remain effective against new influenza viruses

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses.

26 Mar 2021

Changing upper respiratory microbiome in children related to SARS-CoV-2 susceptibility

Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.

25 Mar 2021

Three commonly used antiviral drugs potentially effective at preventing replication of SARS-CoV-2

An international team of researchers has found that three commonly used antiviral and antimalarial drugs are effective in vitro at preventing replication of SARS-CoV-2, the virus that causes COVID-19.

24 Mar 2021

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

A new study describes the use of a combination of virtual and experimental screening protocols to identify potential inhibitors of the virus, which could lead to rapid drug development.

24 Mar 2021

Survey of surge capacity managers captures pandemic preparedness status of the U.S. health care system

A University of Pittsburgh School of Medicine-led survey of dozens of surge capacity managers at hospitals nationwide captures the U.S. health care system's pandemic preparedness status in the months before the first COVID-19 cases were identified in China.

24 Mar 2021

People who received flu shot last season had fewer complication of COVID-19

People who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit, according to a new study.

23 Mar 2021

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

Wearing masks and physical distancing - two key infection prevention strategies implemented to stop the spread of COVID-19 - may have led to the dramatic decrease in rates of common respiratory viral infections, such as influenza.

23 Mar 2021

B.1.1.7 SARS-CoV-2 variant significantly more dangerous

Now, researchers at the University of Exeter, the NHS Foundation Trust, report a significant increase in mortality risk due to the B.1.1.7 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant.

22 Mar 2021

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that it has acted on a request to provide opaganib treatment on an outpatient basis under compassionate use exemption for several Swiss patients suffering from COVID-19 pneumonia.

22 Mar 2021

What are the chief predictors of SARS-CoV-2 infection in children?

A new study seeks to explore the factors associated with the diagnosis in children. The ability to rapidly diagnose COVID-19 in this age group is essential not only for monitoring progressive disease in individual children, but to avert further transmission chains.

22 Mar 2021

Preventing future pandemics by ending the wildlife trade

In this News-Medical interview, we spoke to Professor Diana Bell about the illegal wildlife trade and how we could prevent future pandemics by stopping it.

22 Mar 2021

Study: COVID-19 causes more severe disease and is more lethal than influenza

In a paper published in the Journal of General Internal Medicine, physician-researchers at Beth Israel Deaconess Medical Center assessed the relative impact of COVID-19 on patients hospitalized with the viral infection in March and April 2020, versus patients hospitalized with influenza during the last five flu seasons at the medical center.

19 Mar 2021

COVID-19 patients have higher risk of stroke, finds study

New research found patients hospitalized with COVID-19 had a higher risk of stroke, compared with patients who had similar infectious conditions such as influenza and sepsis in prior studies.

19 Mar 2021

The case for donating US Covid vaccines overseas

A Senate committee grilled federal officials about the shortage of vaccines to protect Americans against a pandemic virus. Two months later, the U.S. public had lost interest in the virus, and millions of vaccines were sitting in warehouses — although poor countries still needed them.

19 Mar 2021

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

19 Mar 2021

Engineering immunogens to focus immune response to SARS-CoV-2

Researchers have designed constructs by adding more glycans and adding the receptor-binding motif from related sarbecoviruses to focus the immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding motif. Such immunogens could potentially also neutralize other variants and coronaviruses.

18 Mar 2021

UK SARS-CoV-2 variant 40% more transmissible than previous strains

Researchers in Japan have estimated that the B.1.1.7 strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that recently emerged in England is 40% more transmissible than strains previously circulating in the country.

18 Mar 2021

Influenza News and Research

Latest Influenza News and Research

New SARS-CoV-2 genome variants identified in US mink

Covid-19 lockdown restrictions may have led to reduction in asthma exacerbations

POSTECH researchers produce artificial lung model using 3D printing

Study: COVID-19 vaccines may remain effective against new influenza viruses

Changing upper respiratory microbiome in children related to SARS-CoV-2 susceptibility

Three commonly used antiviral drugs potentially effective at preventing replication of SARS-CoV-2

New covalent and non-covalent SARS-CoV-2 inhibitors discovered in silico

Survey of surge capacity managers captures pandemic preparedness status of the U.S. health care system

People who received flu shot last season had fewer complication of COVID-19

COVID-19 prevention strategies may have led to a decrease in common respiratory infections

B.1.1.7 SARS-CoV-2 variant significantly more dangerous

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

What are the chief predictors of SARS-CoV-2 infection in children?

Preventing future pandemics by ending the wildlife trade

Study: COVID-19 causes more severe disease and is more lethal than influenza

COVID-19 patients have higher risk of stroke, finds study

The case for donating US Covid vaccines overseas

Researchers explore nanotechnology’s potential to deliver synergistic therapeutics for COVID-19

Engineering immunogens to focus immune response to SARS-CoV-2

UK SARS-CoV-2 variant 40% more transmissible than previous strains

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Influenza News and Research

Latest Influenza News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in